Skip to main content

Transcat, Inc.

corporate_fare Company Profile

Transcat, Inc.

TRNS·NASDAQ·Industrial Applications And Services·CIK 0000099302

TRANSCAT INC is a leading provider of accredited calibration, reliability, maintenance optimization, quality and compliance, validation, Computerized Maintenance Management System (CMMS), and pipette services. The company focuses on delivering services and products to highly regulated industries, including life sciences (pharmaceutical, biotechnology, medical devices, and other FDA-regulated businesses), aerospace and defense, and energy and utilities. Transcat also operates as a value-added distributor, marketing, selling, and renting new and used national and proprietary brand instruments. The company conducts its business through two operating segments: Service and Distribution. Transcat serves approximately 27,000 customers across both segments, with about 20% to 25% of these customers engaging with both business segments. The company's acquisition strategy aims to expand its business segments, grow its core calibration business, and enter new geographic and adjacent markets. This strategy is evidenced by the acquisitions of Essco Calibration Laboratory, LLC (Essco) in fiscal year ended March 28, 2026, and Martin Calibration, LLC (Martin) and Becnel Rental Tools, LLC (Becnel) in fiscal year ended March 29, 2025. In April 2026, Transcat acquired SCM Metrology and Laboratories S. A. (SCM), a privately held calibration services provider based in Costa Rica. Through its Service segment, Transcat offers calibration, repair, inspection, analytical qualifications, preventative maintenance, consulting, and other related services. A majority of these services are processed using the company's proprietary asset management system, CalTrak®, and its online customer portal, C3®.

Transcat, Inc. (NASDAQ:TRNS) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 15 items for TRNS at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-03, rated 8/10. Across its 15 most recent items scored 7 or higher, the top rating is 9/10, with 9 rated 8 or above. Recent SEC coverage for TRNS spans 10-Q, 8-K, 144, 10-K.

Recent high-impact activity:

  • Transcat Q2 FY27: Revenue Up 18% to $97.1M, But Material Weaknesses Persist
  • Transcat Beats on Service Growth, Lifts Full-Year Organic Revenue Outlook
  • Transcat Buys Southeastern Biomedical to Expand Calibration Channel
  • Transcat Q1 Revenue Jumps 22% but Net Income Halves; Material Weaknesses Persist
  • Transcat Q1 FY27: Service Revenue Jumps 27%, Adjusted EBITDA Climbs 19%, and Margins Keep Expanding

Financial Snapshot

Fiscal year ended March 28, 2026
Revenue
$331.88M
Net Income
$5.38M
Diluted EPS
$0.57
Op. Cash Flow
$34.85M
Free Cash Flow
$19.55M
Gross Profit
$108.3M
Operating Income
$13.26M
Cash & Equivalents
$4.94M
Total Debt
$99.89M
Debt / Equity
0.33×
Net Margin
1.6%
Shares Outstanding
9.33M sh
Source: 10-K · filed 2026-05-27 · accession 0001437749-26-018588

Short Interest & Short Volume

2.43 days to cover

FINRA reported short interest of 378,791 shares in TRNS as of the October 30, 2026 settlement, a 14.3% decrease from the prior period — about 2.4 days to cover at its recent average daily volume. On November 20, 2026, 57.5% of TRNS volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)378,791 shares as of October 30, 2026
Change vs prior period▼ 14.3%
Days to cover2.43 at avg daily volume of 155,802
Daily short volume (FINRA facilities)57.5% of 37,954 shares on November 20, 2026
5-day average short volume51.6%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for TRNS, detected from its recent SEC filings.

1 shelf registration

Resale Registration Filed · Final Holdback Shares Released

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with T →
$92.99 +0.02% today
52-week range · as of 2026-11-03 $50.23 – $100
Market cap
$874.37M
Volume
139.8K (0.8× avg)
3-mo avg 173.5K
Live data · 2026-11-22 03:01 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed TRNS - Latest Insights

TRNS
Nov 03, 2026, 4:04 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $89.52
Real-time Price: $92.99 info
Change: +$3.47 (+4%) info
Market Cap: $874.368M info
TRNS
Nov 03, 2026, 4:01 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $89.52
Real-time Price: $92.99 info
Change: +$3.47 (+4%) info
Market Cap: $874.368M info
TRNS
Aug 31, 2026, 9:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $85.84
Real-time Price: $92.99 info
Change: +$7.15 (+8%) info
Market Cap: $874.368M info
TRNS
Aug 04, 2026, 5:20 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $91.89
Real-time Price: $92.99 info
Change: +$1.10 (+1%) info
Market Cap: $874.368M info
TRNS
Aug 04, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $91.89
Real-time Price: $92.99 info
Change: +$1.10 (+1%) info
Market Cap: $874.368M info
TRNS
Aug 04, 2026, 4:01 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $91.89
Real-time Price: $92.99 info
Change: +$1.10 (+1%) info
Market Cap: $874.368M info
TRNS
Jun 01, 2026, 10:08 AM EDT
Filing Type: 144
Importance Score:
9
Price at Filing: $85.63
Real-time Price: $92.99 info
Change: +$7.36 (+9%) info
Market Cap: $874.368M info
TRNS
May 27, 2026, 4:36 PM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $80.32
Real-time Price: $92.99 info
Change: +$12.67 (+16%) info
Market Cap: $874.368M info
TRNS
May 26, 2026, 4:07 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $75.57
Real-time Price: $92.99 info
Change: +$17.42 (+23%) info
Market Cap: $874.368M info
TRNS
May 26, 2026, 4:02 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $75.57
Real-time Price: $92.99 info
Change: +$17.42 (+23%) info
Market Cap: $874.368M info
TRNS
Apr 09, 2026, 4:03 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $80.52
Real-time Price: $92.99 info
Change: +$12.47 (+15%) info
Market Cap: $874.368M info
TRNS
Mar 09, 2026, 4:10 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $71.88
Real-time Price: $92.99 info
Change: +$21.11 (+29%) info
Market Cap: $874.368M info
TRNS
Feb 03, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $63.33
Real-time Price: $92.99 info
Change: +$29.66 (+47%) info
Market Cap: $874.368M info
TRNS
Feb 03, 2026, 4:06 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $63.33
Real-time Price: $92.99 info
Change: +$29.66 (+47%) info
Market Cap: $874.368M info
TRNS
Jan 08, 2026, 8:06 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $60.21
Real-time Price: $92.99 info
Change: +$32.78 (+54%) info
Market Cap: $874.368M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets